Cinemark Holdings, Inc. (NYSE:CNK – Free Report) – Analysts at B. Riley increased their Q3 2024 EPS estimates for Cinemark in a research report issued to clients and investors on Thursday, May 2nd. B. Riley analyst E. Wold now forecasts that the company will post earnings per share of $0.21 for the quarter, up from their prior estimate of $0.16. B. Riley has a “Neutral” rating and a $16.00 price objective on the stock. The consensus estimate for Cinemark’s current full-year earnings is $0.86 per share. B. Riley also issued estimates for Cinemark’s Q4 2024 earnings at $0.30 EPS and Q4 2025 earnings at $0.50 EPS.
Cinemark (NYSE:CNK – Get Free Report) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.40. Cinemark had a return on equity of 69.48% and a net margin of 7.12%. The business had revenue of $579.00 million during the quarter, compared to the consensus estimate of $561.91 million. During the same quarter in the prior year, the company posted ($0.03) earnings per share. The firm’s revenue was down 5.2% on a year-over-year basis.
View Our Latest Research Report on Cinemark
Cinemark Stock Up 2.2 %
Cinemark stock opened at $17.38 on Monday. The firm has a market capitalization of $2.13 billion, a price-to-earnings ratio of 11.99, a PEG ratio of 2.06 and a beta of 2.25. The company’s 50 day simple moving average is $17.94 and its 200 day simple moving average is $15.86. The company has a debt-to-equity ratio of 7.42, a current ratio of 1.48 and a quick ratio of 1.45. Cinemark has a fifty-two week low of $13.19 and a fifty-two week high of $20.40.
Insider Buying and Selling at Cinemark
In other news, insider Wanda Marie Gierhart sold 19,593 shares of the stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $16.75, for a total transaction of $328,182.75. Following the completion of the transaction, the insider now directly owns 179,591 shares in the company, valued at approximately $3,008,149.25. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 2.30% of the company’s stock.
Institutional Investors Weigh In On Cinemark
Institutional investors and hedge funds have recently made changes to their positions in the stock. Commonwealth Equity Services LLC lifted its stake in Cinemark by 4.5% in the 3rd quarter. Commonwealth Equity Services LLC now owns 320,879 shares of the company’s stock valued at $5,888,000 after purchasing an additional 13,720 shares during the last quarter. First National Bank of Hutchinson boosted its stake in shares of Cinemark by 1.4% during the 3rd quarter. First National Bank of Hutchinson now owns 69,853 shares of the company’s stock worth $1,282,000 after acquiring an additional 989 shares during the period. Mitchell Capital Management Co. boosted its stake in shares of Cinemark by 0.4% during the 3rd quarter. Mitchell Capital Management Co. now owns 387,784 shares of the company’s stock worth $7,116,000 after acquiring an additional 1,470 shares during the period. Capula Management Ltd increased its holdings in shares of Cinemark by 53.4% during the 3rd quarter. Capula Management Ltd now owns 57,040 shares of the company’s stock worth $1,047,000 after acquiring an additional 19,860 shares during the last quarter. Finally, NBC Securities Inc. bought a new stake in Cinemark in the 3rd quarter valued at $74,000.
About Cinemark
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Featured Stories
- Five stocks we like better than Cinemark
- Pros And Cons Of Monthly Dividend Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- The How and Why of Investing in Gold Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Use the MarketBeat Stock Screener
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.